Member Info for handybrownone

Details of the fundraise are in the RNS - anything between 4-5p I will certainly take up.

The other thing that could also pop out of the blue would be a major US partner. They've done this all on their own and someone will have noticed and made enquiries. It is clearly something that needs a major US partner.

I think we expect a trading update soon. Hopefully there will be some pleasant news. We've had a bad run so if we get 1. Stop the rot in UK and hopefully flat or upwards 2. Some update on paeditric use in USA? This is completely unmet need and could get a lot of noise 3. International ex-USA sales to go 4. Some indictaion on how roll-out will progress in 2H in USA 5. Details on the third party products that they have dropped hints about All are good for the SP but something on all 5 would be amazing.....

Directors talk - search Deltex - the 17th Sep interview. In fact he doesn't do many so I listened with a keen ear. I have been following for 5+ years and it is certainly the best time to buy now.

Directors talk - search Deltex - the 17th Sep interview. In fact he doesn't do many so I listened with a keen ear. I have been following for 5+ years and it is certainly the best time to buy now.

listen to http://www.***************************/deltex-medical-group-plc-ewan-philips-u-s-markets-progressing-very-very-well/412678573 Listen at 5'mins. Three choices for.....If USA takes off......

because people are buiying. So 2016 Q1 the issues of the 1 million loan - conversion to equity or refinance to avoid placement. They said sales in 2H will be stronger. Let's see. Also lots of comments that this company is for sale. National roll out iin USA is critical. Use in paeditrics is I think significnat.

for the opioid nasal product. I am expecting approval and a nice bump up

It seems we were both wrong! Which is not hard to do in AIM it seems - LGO trains smash and SRT underdelivery. I hold SRT long term

finallly gave up on LGO - and the price here is too good.

I still have a small holding...disappointing probe sales. There is discussion of a US national launch from 2016 but do we have enough cash? Probably not.....It might reach the stage where if the cash doesn't come through the BoD might be forced to think of a sale? Investors have been patient - or will they give the BoD one last try?

Not an expert but I think he's saying we are about to be shafted and I did try to warn you!

Drax issued guidance that budget cut will affect EBITDA 30m this year and 60mn next year and then falling to zero anyway by by 2020 - even without the cut from the budget it was going to disappear. From the 2014 reports only 99m in debts "Property, plant and equipment – The net book value of the Group’s property, plant and equipment was £1.7 billion at 31 December 2014" So MCAP cust over 1bn and is below Book value - how often do you see that? That is always a flag to buy. Does it make a profit? 400m Gross profits on 2.8bn turnover and 229EBITDA Why chart is so bad then? Continuing squeeze on profits and continutaion of squeeze is predicted. recovery not fully expect until next year I think SP drop is overdone. dividends will be paid otherwise SP will fall off a cliff and now it is approaching more than 4% This is ripe for a takeover and its bite sized Its a BUY

Bought a few more - but I really like Amphion - they hold 11.51% of Kromek AND they hold around 40% of Motif. Take 11% of MCAP of Kromek and add it to 40% of MCAP of Motif then look at MCAP of AMphion. Amphion have other things in portfolio as well. Motif is interesting an antibiotic in PHase III and and entire MCAP of 40m. IF IF IF phase III is positive it will at least double probably treble. If not positive it is worth zero. But I do like Kromek - it has products niche - high barrier to entry and there are sales - just wiating for the J curve to kick in.

Or not! - Strategic review until the autumn - so basically limbo

Ha - I just calculated 2 Parl to be 57p - I will take the HL figure! Just popping back to see what peeps wer up to. Time to buy back in 52 week low - divi is 4% and paid in less than 2 weeks from ex-divi. I like this share - is sentiment general still down just generally in banks and why SP low - director sell still impacting - what is it? I havent been on this BB for 3 months! Back after seeing SP creeping down

DEMG becoming my start performer - some buying is going on and its not just the directors! This really was baragin at 4p!

Many false dawns! But worth watching as it rises very quickly.

I think so as nice niche player - results today help as Indivior dont have the sales force to seel risperidone in the USA - the need a partner at least

Glad I bought yesterday.